Comparing axillary radiotherapy and lymphadenectomy in breast cancer patients after neoadjuvant therapy
Official title: Axillary Lymph Node Dissection Versus Axillary Radiotherapy in Breast Cancer Patients With Positive Sentinel Node After Neoadjuvant Therapy: A Multicenter Randomized Study
Run by Hospital Universitari de Bellvitge · NCT04889924 · Data updated 2026-11-12
This study is testing whether using axillary radiotherapy instead of surgery can help breast cancer patients who have had neoadjuvant treatment avoid lymphedema.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 820 (estimated) |
| Sponsor | Hospital Universitari de Bellvitge Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 61 sites (Sydney, New South Wales and 60 other locations) |
| Status | Recruiting |
| Started | June 11, 2021 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2028 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT04889924 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are breast cancer patients with sentinel node involvement who have received neoadjuvant systemic treatment and meet specific eligibility criteria.
✕Probably not a fit
Patients with more advanced nodal involvement (cN2) or those who have had prior breast surgery for ipsilateral cancer may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates whether axillary radiotherapy (ART) can reduce the risk of lymphedema compared to axillary lymph node dissection (ALND) in breast cancer patients who have undergone neoadjuvant systemic treatment and have positive sentinel nodes. The study is a prospective, randomized, open-label, multicenter trial with an estimated sample size of 1660 patients over five years. Participants will be stratified based on their neoadjuvant treatment regimen, and both groups will be monitored for recurrence, overall survival, and quality of life. An interim analysis will be conducted after recruiting the first 820 patients to assess early outcomes.
Why it matters
Potential benefit: If successful, this study could provide a less invasive treatment option that minimizes the risk of lymphedema for breast cancer patients.
How similar studies have gone: Previous studies have shown that omitting axillary lymph node dissection can reduce lymphedema risk, but this specific approach in the context of neoadjuvant therapy is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * T1-T4 N0/ T0-T4 N1 at diagnosis and subsidiary of neoadjuvant treatment * Post-CT SLN with ≤2 macrometastasis/micrometastasis or ITCs * Post-CT axillary response by ultrasound or MRI * Complete at least 70% of neoadjuvant chemotherapy and 6 months of endocrine treatment. Exclusion Criteria: * cN2 * ypN0 * History of breast surgery for ipsilateral cancer in the last 10 years * History of other cancer in the last 5 years, except squamous carcinoma of the skin.
Where it's running
-
GenesisCare Mater
Sydney, New South Wales, Australia Recruiting -
GenesisCare North Shore
Sydney, New South Wales, Australia Recruiting -
GenesisCare Frenchs Forest
Sydney, New South Wales, Australia Recruiting -
GenesisCare Norwest
Sydney, New South Wales, Australia Recruiting -
GenesisCare Hurstville
Sydney, New South Wales, Australia Recruiting -
GenesisCare Campbelltown
Sydney, New South Wales, Australia Recruiting
Show 44 more locations
-
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, Spain Recruiting -
Instituto Catalán de Oncología de Badalona
Badalona, Barcelona, Spain Recruiting -
Hospital Comarcal Sant Jaume de Calella
Calella, Barcelona, Spain Recruiting -
Hospital General de Granollers
Granollers, Barcelona, Spain Recruiting -
Consorci Sanitari Integral
L'Hospitalet de Llobregat, Barcelona, Spain Recruiting -
Hospital Universitario de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain Recruiting -
Instituto Catalán de Oncología- Hospital Duran i Reynals
L'Hospitalet de Llobregat, Barcelona, Spain Recruiting -
Fundación Althaia Manresa
Manresa, Barcelona, Spain Recruiting -
Hospital de Mataró
Mataró, Barcelona, Spain Recruiting -
Hospital Universitario Mútua Terrassa
Terrassa, Barcelona, Spain Recruiting -
Consorci Sanitari de Terrassa
Terrassa, Barcelona, Spain Recruiting -
Hospital de Viladecans
Viladecans, Barcelona, Spain Recruiting -
Hospital Universitario de Cruces
Barakaldo, Bizkaia, Spain Recruiting -
Hospital Universitario Galdakao-Usansolo
Galdakao, Bizkaia, Spain Recruiting -
Hospital Universitario de Donostia
Donostia / San Sebastian, Gipuzkoa, Spain Recruiting -
Hospital Universitario Príncipe de Asturias
Alcalá de Henares, Madrid, Spain Recruiting -
Hospital Universitario Severo Ochoa
Leganés, Madrid, Spain Recruiting -
Hospital Universitario Puerta De Hierro
Majadahonda, Madrid, Spain Recruiting -
Hospital Universitario Infanta Cristina
Parla, Madrid, Spain Recruiting -
Hospital Clínico Universitario Virgen de la Arrixaca
El Palmar, Murcia, Spain Recruiting -
Hospital Ribera Povisa
Vigo, Pontevedra, Spain Recruiting -
Hospital Álvaro Cunqueiro
Vigo, Pontevedra, Spain Recruiting -
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain Recruiting -
Hospital Universitario Sant Joan de Reus
Reus, Tarragona, Spain Recruiting -
Hospital Universitario de A Coruña
A Coruña, Spain Recruiting -
Hospital del Mar
Barcelona, Spain Recruiting -
Hospital de la Santa Cruz y San Pablo
Barcelona, Spain Recruiting -
Hospital Clínico y Provincial de Barcelona
Barcelona, Spain Recruiting -
Hospital Universitario de Burgos
Burgos, Spain Recruiting -
Hospital Universitario de Gerona Doctor Josep Trueta
Girona, Spain Recruiting -
Institut Catalán de Oncología de Girona
Girona, Spain Recruiting -
Hospital Universitario Virgen de las Nieves
Granada, Spain Recruiting -
Hospital General Universitario Gregorio Marañón
Madrid, Spain Recruiting -
Hospital Universitario Ramón y Cajal
Madrid, Spain Recruiting -
Hospital Universitario 12 de Octubre
Madrid, Spain Recruiting -
Hospital Universitario La Paz
Madrid, Spain Recruiting -
Hospital Universitario HM Sanchinarro
Madrid, Spain Recruiting -
Hospital Universitario Infanta Sofía- Fundación de Inv. Biomédica H. Infanta Sofía
Madrid, Spain Recruiting -
Hospital Regional Universitario de Málaga
Málaga, Spain Recruiting -
Hospital Universitario Virgen de la Victoria
Málaga, Spain Recruiting -
Hospital Universitario de Navarra
Pamplona, Spain Recruiting -
Hospital Montecelo
Pontevedra, Spain Recruiting -
Hospital Universitario Nuestra Señora de Candelaria
Santa Cruz de Tenerife, Spain Recruiting -
Hospital General de Segovia
Segovia, Spain Recruiting
+11 more sites. See ClinicalTrials.gov for the full list.
Study contacts
- Principal investigator: Maria Laplana, MDPhD — Hospital Clínico y Provincial de Barcelona
- Study coordinator: Amparo Garcia-Tejedor, MDPhD
- Email: agarciat@bellvitgehospital.cat
- Phone: 34 + 932607695
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gait Changes in Breast Cancer Patients Receiving Chemotherapy
This study tests how chemotherapy affects walking and balance in women with breast cancer.
-
VR-guided mindfulness for anxiety, sleep, comfort, and fatigue in women with breast cancer undergoing chemotherapy
This study tests whether a virtual reality–based mindfulness program can help women with breast cancer feel less anxious, sleep better, feel more comfortable, and have less fatigue during chemotherapy.
-
Using indocyanine green to find sentinel lymph nodes during mastectomy
This pilot will test whether injecting indocyanine green and using fluorescence during mastectomy can find sentinel lymph nodes in women with clinically node-negative invasive breast cancer.
-
Using indocyanine green to identify sentinel lymph nodes during breast cancer surgery
This project tests whether indocyanine green dye and a fluorescence camera can be used instead of the radioactive tracer to find sentinel lymph nodes in adults having breast cancer surgery who are clinically node-negative.
-
Targeted sentinel node biopsy for breast cancer patients with limited axillary nodal disease
This audit will test if removing the marked node along with the sentinel nodes can identify people with only 1–2 positive axillary nodes so some can avoid a full axillary dissection, for adults with cT1-2 breast cancer and biopsy-proven axillary metastases with no more than two abnormal nodes on imaging.
-
Using advanced imaging technology for early-stage breast cancer surgery
This study is testing a new imaging tool during breast cancer surgery to see if it can help doctors find lymph nodes more accurately and improve treatment for patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.